Mrs Jacqueline Marie Pendergrass, LPN | |
1255 Laurel Street, Florence, OR 97439-0119 | |
(541) 997-4015 | |
Not Available |
Full Name | Mrs Jacqueline Marie Pendergrass |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 1255 Laurel Street, Florence, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447570437 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 200630279LPN (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Jacqueline Marie Pendergrass, LPN Po Box 1839, Florence, OR 97439-0119 Ph: (541) 997-4015 | Mrs Jacqueline Marie Pendergrass, LPN 1255 Laurel Street, Florence, OR 97439-0119 Ph: (541) 997-4015 |
News Archive
Fluid milk consumption among children is vital, as adequate consumption of dairy products, especially during childhood, has beneficial health outcomes later in life.
A study of general surgery residents at The Johns Hopkins Hospital suggests that in the efforts to prevent dangerous blood clots among hospitalized patients, regular, one-on-one feedback and written report cards work a lot better than the usual group lectures that newly minted surgeons receive as part of their training.
A study in the October 15 issue of the Journal of Clinical Sleep Medicine shows that respiratory sinus arrhythmia (RSA) is a significant predictor of insomnia in women with breast cancer and confirmed that longer nocturnal wake episodes were associated with a flatter diurnal cortisol slope.
You don't always need to build up a big sweat to reap the healing benefits of physical activity. Research has found that even a low-intense exercise program can reduce depression symptoms and boost physical therapy results in recovering stroke patients.
BHR Pharma, LLC (BHR) announced today that it will initiate a global, Phase 3, multi-center pivotal trial (www.synapse-trial.com) to evaluate the effectiveness of its proprietary BHR-100 intravenous progesterone infusion product as a neuroprotective agent for treating severe traumatic brain injury (TBI) patients in early 2010.
› Verified 5 days ago